nach oben

AIDS and Behavior

Erschienen in:

01.09.2013 | Original Paper

Sexual Risk Behavior Associated with Transition to Injection Among Young Non-Injecting Heroin Users

verfasst von: Mary Ellen Mackesy-Amiti, Basmattee Boodram, Chyvette Williams, Lawrence J. Ouellet, Dita Broz

Erschienen in: AIDS and Behavior | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the effects of transitioning from non-injection heroin use to injection drug use on sexual risk behavior. Non-injecting heroin users age 16–30 were enrolled from 2002 to 2005, and were re-interviewed at 6-month intervals for up to three years; 561 participants completed at least one follow-up interview. The majority of participants were non-Hispanic (NH) Black (54 %), 23 % were Hispanic, and 21 % were NH white. During follow-up, 154 participants (27.5 %) transitioned to injecting drugs. Logistic regression analyses were conducted using generalized estimating equations (GEE) to estimate the effect of transition to injection drug use on changes in sexual risk behavior during follow-up. Transition to injection drug use during follow-up was associated with increased likelihood of sexual risk behavior, especially for men. Harm reduction efforts that focus on preventing initiation or return to injection among non-injecting drug users may also ameliorate HIV sexual risk behaviors.

Santibanez S, Garfein R, Swartzendruber A, Purcell D, Paxton L, Greenberg A. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006;83(1):86–100.PubMedCrossRef

Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58(3):219–26.PubMedCrossRef

Huo D, Ouellet LJ. Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois. Sex Transm Dis. 2009;36(1):35–40.PubMedCrossRef

Kapadia F, Latka MH, Wu Y, Strathdee SA, Mackesy-Amiti ME, Hudson SM, et al. Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics. AIDS Behav. 2011;15(7):1309–18.PubMedCrossRef

Hagan H, Perlman DC, Des Jarlais DC. Sexual risk and HIV infection among drug users in New York City: a pilot study. Subst Use Misuse. 2011;46(2/3):201–7.PubMedCrossRef

Arasteh K, Des Jarlais DC, Perlis TE. Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend. 2008;95(1–2):54–61.PubMedCrossRef

Neaigus A, Gyarmathy VA, Miller M, Frajzyngier V, Zhao M, Friedman SR, et al. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend. 2007;89(2–3):234–43.PubMedCrossRef

DesJarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Semaan S. Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health. 2011;101(7):1277–83.CrossRef

Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705–14.PubMedCrossRef

10.

Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-Year perspective. Arch Intern Med. 2001;161(10):1281–8.PubMedCrossRef

11.

Strathdee SA. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int J Drug Policy. 2003;14(1):79–81.CrossRef

12.

Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef

13.

Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.PubMedCrossRef

14.

Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66(2):189–98.PubMedCrossRef

15.

Miller CL, Pearce ME, Moniruzzaman A, Thomas V, Christian W, Schechter MT, et al. The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. Can Med Assoc J. 2011;183(10):1147–54.CrossRef

16.

Griffiths P, Gossop M, Powis B, Strang J. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction. 1994;89(3):301–9.PubMedCrossRef

17.

Grund J-PC. From the straw to the needle? Determinants of heroin administration routes. In: Inciardi JA, Harrison LD, editors. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage; 1998. p. 215–58.

18.

Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96(6):847–60.PubMedCrossRef

19.

Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.PubMedCrossRef

20.

Roy É, Haley N, Leclerc P, Cédras L, Blais L, Boivin J-F. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105.PubMedCrossRef

21.

Sherman SG, Smith L, Laney G, Strathdee SA. Social influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. Int J Drug Policy. 2002;13(2):113–20.CrossRef

22.

Valdez A, Cepeda A, Neaigus A, Russell A. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy. 2008;19(6):442–9.PubMedCrossRef

23.

Broz D, Ouellet LJ. Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago. Subst Use Misuse. 2010;45(12):2000–25.PubMedCrossRef

24.

Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91(Supplement 1):S4–17.PubMedCrossRef

25.

Broz D. Transitions to injection and risk of HIV, HBV and HCV among young non-injecting heroin users in Chicago [Ph.D. dissertation]. Chicago: University of Illinois at Chicago, United States; 2009.

26.

Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353(9165):1657–61.PubMedCrossRef

27.

Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280(5365):867–73.PubMedCrossRef

Titel: Sexual Risk Behavior Associated with Transition to Injection Among Young Non-Injecting Heroin Users
verfasst von: Mary Ellen Mackesy-Amiti
Basmattee Boodram
Chyvette Williams
Lawrence J. Ouellet
Dita Broz
Publikationsdatum: 01.09.2013
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 7/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-012-0335-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2013

From Coitus to Concurrency: Sexual Partnership Characteristics and Risk Behaviors of 15–19 Year Old Men Recruited from Urban Venues in Tanzania

Community Influences on Married Men’s Uptake of HIV Testing in Eight African Countries

Respondent Driven Sampling for HIV Biological and Behavioral Surveillance in Latin America and the Caribbean

HIV Among Injection Drug Users and Their Intimate Partners in Almaty, Kazakhstan

Acceptability and Feasibility of Cash Transfers for HIV Prevention Among Adolescent South African Women

A Study of Financial Incentives to Reduce Plasma HIV RNA Among Patients in Care